TMCnet News
3D Bioprinting Report 2017 - Gaining Momentum in Academic and Commercial Settings - Research and MarketsDUBLIN, May 16, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "3D Bioprinting 2017-2027: Technologies, Markets, Forecasts" report to their offering.  Interest in 3D bioprinting has been gaining momentum in recent years, both in the academic and commercial settings. Between 2014 and 2015, the market welcomed numerous 3D bioprinting companies, and new start-ups, spin-outs, and subsidiaries are continuing to emerge. Though investment in the field has been driven on by the futuristic goal of providing solutions for regenerative by way of fabricating organs for transplant, more realistic applications in product development and testing have shown great promise and are already being marketed. 3D bioprinting can be defined in a variety of ways, and each definition includes and excludes large swathes of key biotechnology markets. In this report, the analyst has defined 3D bioprinting as the deposition of living cells in a spatially controlled manner in the absence of any pre-existing scaffold and in more than a single layer. Companies Mentioned
Key Topics Covered: 1. EXECUTIVE SUMMARY For more information about this report visit http://www.researchandmarkets.com/research/ld37d6/3d_bioprinting Media Contact: Laura Wood, Senior Manager
|